WRBY
Research Snapshot
Static fundamentals, valuation context, and investor signals for Warby Parker Inc. (WRBY).
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
0.4%
ROIC, 5.0% FCF margin
Growth
17.2%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 2.3x current ratio
Superinvestors
2
Top: Thomas Russo (0.0%)
Strengths to research
- Revenue compounded at 17.2% over five years.
- Free cash flow compounded at 28.1% over five years.
- Debt/equity looks manageable at 0.0x.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 7 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for WRBY.
Grade C
48
/ 100
Financial Charts
No financial data available for WRBY (annual).
2 superinvestors own WRBY
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 135,090 | $3M | 0.00% | 0.0% |
| Thomas Russo Gardner Russo & Quinn | 80,000 | $2M | 0.02% | 0.0% |